Facebook-f Instagram Twitter Linkedin-in Youtube

Nextleaf Solutions Granted 50th Patent and Provides Commercial Update (CSE:OILS) (OTCQB:OILFF)

  • October 26, 2020

Home / Press Releases / Nextleaf Solutions Granted 50th Patent and Provides Commercial Update (CSE:OILS) (OTCQB:OILFF)

Nextleaf Solutions Ltd.  Canada’s most innovative cannabis extractor, is pleased to provide shareholders with the following commercial update:

Vape Cartridges Powered by OILSTM now Available in the Provincial Retail Market

Vape cartridges powered by OILS high purity distillate are available at cannabis retailers in the Saskatchewan adult-use market, with more provinces to be announced in the coming months. The launch of vape cartridges into provincial retail through the Company’s Commercial Partners Program represents an important milestone for OILS in the commercialization of its intellectual property (“IP”) portfolio.

“This represents the first step in OILS entering the adult-use market in a meaningful way. We look forward to a sequence of product launches in the months ahead, as Nextleaf supports the launch of innovative cannabis products through its Commercial Partners Program,” said Nextleaf CEO Paul Pedersen.

Commercial and Supply Update

The Company, through its wholly owned subsidiary Nextleaf Labs Ltd. (“Nextleaf Labs”), completed the bulk sale of premium tetrahydrocannabinol (THC) distillate to a British Columbia (BC)-based licensed cannabis processor focused on the manufacturing and distribution of branded cannabis consumer products through provincial retail.

Additionally, Nextleaf is pleased to announce the Company has entered into a bulk cannabis distillate supply agreement (the “Sales Agreement”) with a BC-based licensed processor and one of Canada’s top selling cannabis brands (the “Client”). Pursuant to the Sales Agreement, Nextleaf will supply over 100 kilograms of cannabidiol (CBD) distillate to the Client for the purposes of manufacturing white label CBD based products.

“We see this as the beginning of a long-term relationship with a cannabis brand that does some of the highest sales volume in Canada,” stated Nextleaf CFO Charles Ackerman.

Nextleaf has entered into a bulk cannabis biomass supply agreement (the “Supply Agreement”) whereby the Client supplies over 2,000 kilograms of THC and CBD cannabis biomass for Nextleaf Labs to process into distilled THC and CBD oils using Nextleaf’s patented extraction platform.

Since commencing commercial oil production earlier this year, Nextleaf has contracted supply of over 27,000 kilograms of dried cannabis biomass from licensed cultivators through the OILS Commercial Partners Program. Pursuant to the program, Nextleaf Labs efficiently toll processes cannabis biomass into distilled THC and CBD oils, and sells the resulting bulk cannabinoids through Nextleaf’s Commercial Partners and the Canadian wholesale market.

“We believe our investment in IP and our existing fixed asset base will help OILS ensure the long-term sustainability of our business, provide a robust platform to scale, and a clear competitive advantage to provide high quality cannabinoids produced through Nextleaf’s ultra-efficient cannabis oil refinery,” Ackerman concluded.

Research and Development

Nextleaf continues to bolster its IP portfolio by commencing trials of its proprietary pesticide remediation process with the goal of solving the industry’s prevalent pesticide drift challenge. The current contamination struggles experienced by licensed cultivators growing in repurposed greenhouses and outdoor fields is being magnified when cannabis and hemp biomass is processed into concentrated oils. The Company hopes to provide its clients with a viable scaled solution next year and believes the proprietary technology will have significant commercial value in other jurisdictions that require legal cannabis products to be tested for banned pesticides.

With increased production of cannabis 2.0 products across Canada, product differentiation has become paramount for producers as they compete for market share. Nextleaf plans to begin offering sensory and palatability trials under Nextleaf Labs’ existing Research licence upon Health Canada approving the licence amendment, as an additional value-added B2B service.

Nextleaf is developing IP around unique formulations and delivery methods of THC and CBD. The Company increased its R&D efforts focused on commercializing a THC powder format of its Rapid Emulsion Technology by OILS™. With dissolvable THC powder outselling most ready to drink infused beverages in Canada, Nextleaf is preparing to launch its patent pending rapid emulsion technology in THC drops and dissolvable powder formats.

Nextleaf Receives 50th Issued Patent

The United States Patent and Trademark Office has granted OILS a patent for the formulation of a solventless extract. In provinces where vape cartridges cannot be sold, solventless extracts are the top selling concentrate product. This patent continues Nextleaf’s success rate of 100% pending to issued patents and marks the 50th issued patent for the extraction, purification, and delivery of cannabinoids. The Company has been issued patents in the key markets of the United States, Canada, Israel, Australia, New Zealand, Colombia, South Africa, and across the European Union.

“I’m extremely proud of our team for receiving its 50th issued patent, which represents the second largest patent portfolio of any cannabis company,” said Paul Pedersen, CEO of Nextleaf Solutions.

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.

For more information please contact:
Jason McBride
604-283-2301 (ext. 219)
investors@nextleafsolutions.com

On behalf of the Board of Directors of OILS,

Paul Pedersen, CEO

CAUTIONARY STATEMENT

Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those  regarding the Company’s ability to capitalize on its IP portfolio,  the Company’s  strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed or approved the contents of this press release.

Interested in investing in Nextleaf?

Exclusive access to monthly insights from Canada’s most innovative cannabis processor. Join over 7000+ subscribers world-wide!

sign up for updates

The Latest from OILS

Loading...
Cannabis, Chemistry, & Agrology: Why Professional Designations Matter Within The Cannabis Industry

Cannabis, Chemistry, & Agrology: Why Professional Designations Matter Within The Cannabis Industry

Professional designations and accreditation can be a meaningful and valuable way to differentiate the strength of the team behind a brand or company, and their ability to deliver operational excellence and quality.
Read Now
Loading...
THC-

Not All THC Analysis is Created Equal

Canada’s most innovative extraction company, Nextleaf Solutions (CSE: OILS | OTCQB: OILFF | FSE: L0MA) is developing technology for distilling THC and CBD oils used to formulate popular 2.0 products including vape pens, edibles and beverages
Read Now
Loading...
What Does Distillate Cost in Canada?

What Does Distillate Cost In Canada?

There is a combination of fixed and fluctuating factors that affect pricing. This is relevant context for cultivators looking to maximize the value of their harvest, and manufacturers looking to create competitive pricing in their portfolio of cannabis derivative products.
Read Now

Exclusive access to monthly insights from the world’s most innovative cannabis
processor. Join over 7000+ subscribers world-wide.

info@nextleafsolutions.com

  • Privacy
  • Cookie Policy
Menu
  • Privacy
  • Cookie Policy
Linkedin-in Facebook-f Instagram Twitter Youtube
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. Read More
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
  • Our Story
    • Team
  • Brands
  • Extraction Tech
    • Rapid Emulsion Tech
  • Services
    • Toll Processing
    • Bulk Sales &
      Purchasing
    • Research &
      Product Development
  • Investor
    • Press Releases
    • Financial Filings
    • Investor Deck
  • Media
    • Insights
    • News
  • Contact
Menu
  • Our Story
    • Team
  • Brands
  • Extraction Tech
    • Rapid Emulsion Tech
  • Services
    • Toll Processing
    • Bulk Sales &
      Purchasing
    • Research &
      Product Development
  • Investor
    • Press Releases
    • Financial Filings
    • Investor Deck
  • Media
    • Insights
    • News
  • Contact
Menu
  • Our Story
    • Team
  • Brands
  • Extraction Tech
    • Rapid Emulsion Tech
  • Services
    • Toll Processing
    • Bulk Sales &
      Purchasing
    • Research &
      Product Development
  • Investor
    • Press Releases
    • Financial Filings
    • Investor Deck
  • Media
    • Insights
    • News
  • Contact
Facebook-f Instagram Twitter Linkedin-in Youtube

SIGN-UP NOW!

Exclusive access to monthly insights from the world’s most innovative cannabis processor. Join over 7000+ subscribers world-wide.
Unsubscribe at any time. Your email will not be shared or distributed. View our privacy policy.

Confirm Your Age

By selecting yes, I certify that I am of legal age in my jurisdiction to consume cannabis.

YES
YES
NO
Remember my answer

INVEST IN THE FUTURE OF CANNABIS

Please enter your email below to receive the Nextleaf Solutions Investor Kit.
Unsubscribe at any time. Your email will not be shared or distributed. View our privacy policy.